Estrogen Receptor-α36 Mediates EGFR-SGK1 Signaling-Related Erk Activation in Gastric Cancer
Cells · 26.04.2026 · 15 (9) · 787
DOI: 10.3390/cells15090787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 26.04.2026. Verfasst von Yibo Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cognitive and Affective Disorders, School of Medicine, Jianghan University, No. 8 Sanjiaohu Road, Wuhan 430056, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Protein Serine-Threonine Kinases, Immediate-Early Proteins, Estrogen Receptor alpha. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project Funding, Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Gastric cancer is a prevalent and aggressive malignancy driven by complex signaling networks. Estrogen receptor-α36 (ER-α36), a membrane-localized receptor, mediates non-genomic signaling and promotes tumor progression. ER-α36 can interact with epidermal growth factor receptor (EGFR) to activate downstream mitogen-activated protein kinase (MAPK) signaling, but the detailed mechanism in gastric cancer remains unclear. This study aimed to explore whether ER-α36 promotes gastric cancer progression by regulating serum and glucocorticoid-regulated kinase 1 (SGK1)-mediated Erk1/2 activation.Methods:We collected 53 human gastric adenocarcinoma specimens and detected ER-α36 expression by immunohistochemistry. Bioinformatics analysis was used to identify ER-α36-related kinases. Gastric cancer cell lines (SGC7901, HGC27, NCI-N87, and MFC) were used for in vitro studies. Western blotting, qRT-PCR, immunofluorescence, co-immunoprecipitation (Co-IP), wound healing, MTT, and Transwell invasion analyses, and nude mouse orthotopic tumor models were applied to investigate the function and mechanism of the ER-α36/SGK1/Erk1/2 axis.
Results
ER-α36 was positively expressed in 62.3% of gastric adenocarcinoma tissues and was associated with poor differentiation and prognosis. SGK1 was identified as a key kinase downstream of ER-α36. ER-α36, SGK1, and p-Erk1/2 were co-upregulated in gastric cancer tissues and cells. ER-α36 regulated Raf/MEK1/2/Erk1/2 phosphorylation in an SGK1-dependent manner. EGF-induced Erk1/2 activation required both ER-α36 and SGK1. Overexpression of ER-α36 promoted the proliferation, migration, and invasion of gastric cancer cells, while SGK1 knockdown abolished these oncogenic effects. In vivo experiments confirmed that ER-α36 promoted gastric tumor growth and EGFR/Erk signaling, which was attenuated by SGK1 knockdown.
Conclusions
ER-α36 contributes to the malignant progression of gastric adenocarcinoma by activating the Erk1/2 pathway through SGK1. The ER-α36–SGK1–Erk1/2 axis may serve as a novel therapeutic target for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cognitive and Affective Disorders, School of Medicine, Jianghan University, No. 8 Sanjiaohu Road, Wuhan 430056, China.
- Institutes of Biomedical Sciences, School of Medicine, Jianghan University, No. 8 Sanjiaohu Road, Wuhan 430056, China.
- Department of Pathology and Pathophysiology, School of Medicine, Jianghan University, No. 8 Sanjiaohu Road, Wuhan 430056, China.
ORCID-Profile: Yifan Xiao, Qingqing Xu, Wenli Huang, Xiji Shu, Yiyuan Xia
Förderung
- Scientific Research Project Funding
- Key Research and Development Program
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
- Hubei Provincial Natural Science Foundation for Distinguished Young Scholars
- Key Research and Development Program of Wuhan
- Scientific Research Project Funding of Jianghan University
Zitieren
APA
Zhang, Y., Zhou, H., Xiao, Y., Yang, S., Xu, Q., Liu, X., Huang, W., Pi, M., Xiong, Q., Wang, X., Shu, X., & Xia, Y. (2026). Estrogen Receptor-α36 Mediates EGFR-SGK1 Signaling-Related Erk Activation in Gastric Cancer. Cells, 15(9), 787. https://doi.org/10.3390/cells15090787
Vancouver
Zhang Y, Zhou H, Xiao Y, Yang S, Xu Q, Liu X, et al. Estrogen Receptor-α36 Mediates EGFR-SGK1 Signaling-Related Erk Activation in Gastric Cancer. Cells. 2026;15(9):787. doi:10.3390/cells15090787
BibTeX
@article{Zhang2026,
author = {Zhang, Yibo and Zhou, Hongyan and Xiao, Yifan and Yang, Shubing and Xu, Qingqing and Liu, Xin and Huang, Wenli and Pi, Mingshan and Xiong, Qi and Wang, Xiaochuan and Shu, Xiji and Xia, Yiyuan},
title = {Estrogen Receptor-α36 Mediates EGFR-SGK1 Signaling-Related Erk Activation in Gastric Cancer},
journal = {Cells},
year = {2026},
volume = {15},
number = {9},
pages = {787},
doi = {10.3390/cells15090787}
}
EUVIMED